CD9 and prostate carcinoma: EVs from individuals with prostate cancer typically include cancer-related proteins such as CD9, CD81, and TSG101, as well as Annexin A2, Fatty Acid Synthase (FASN), and a prostate cancer-specific biomarker termed FOLH1 (Prostate Specific Membrane Antigen or PSMA) (122).